Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,461

MORGANTOWN — World-leading brain experts at West Virginia University’s Rockefeller Neuroscience Institute are celebrating the historic breakthrough Alzheimer patients around the global have been waiting for.

“For Alzheimer’s, there’s not that many treatments available despite hundreds of clinical trials over the past two decades and billions of dollars spent,” said Dr. Ali Rezai, a neurosurgeon at WVU who led the team of investigators that successfully performed a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s.

The WVU team tested the innovative treatment in collaboration with INSIGHTEC, an Israeli medical technology company. Earlier this year, INSIGHTEC was approved by the U.S. Food and Drug Administration to begin a phase II clinical trial of the procedure and selected the WVU Rockefeller Neuroscience Institute as the first site in the United States for the trial.

Read more

Scientists are now closer than ever to being able to use graphene as a superconductor – to conduct electricity with zero resistance – making it useful for developing energy efficient gadgets, improving medical research, upgrading power grids, and much more besides.

The key to the new approach is heating a silicon carbide (SiC) crystal, itself a superconductor, until the silicon atoms have all evaporated. This leaves two graphene layers on top of each other in a way that, in certain conditions, offers no resistance to electrical current.

A similar dual-layer approach was also successfully used to turn graphene into a superconductor earlier this year. The difference here is the layers don’t have to be carefully angled on top of each other, which should make it easier to reproduce at scale.

Read more

Motivation is such an intangible aspect of the human spirit that we often forget it has very real, neurochemical origins. We admire it in others and strive for it in ourselves (see: every Nike ad ever made), and now we are getting closer to potentially inducing that motivational feeling with drugs.

John Salamone, Ph.D., a professor at the University of Connecticut with a background in neural and behavioral pharmacology, has been working with the drug company Chronos Therapeutics to develop a drug that can restore motivation in people who have lost it — whether that’s due to the symptoms of depression, struggle with disease, or otherwise. He unveiled his early results on rats this week in a presentation at the Society For Neuroscience’s conference in San Diego, where he tells Inverse his board was bustling with activity:

“Basically we stood there for four hours and were busy the entire time,” says Salamone. The reception was overwhelmingly positive, he adds. “We didn’t have anyone say ‘This is crazy! This will never work!’”.

Read more

Just got these links: #Transhumanism is covered extensively in this hour long show from Discovery Channel that aired a few weeks ago. My 20-min interview in this program starts at 19 minutes: https://www.discovery.com/tv-shows/expedition-unknown/full-e…-dark-side & the YouTube link: https://www.youtube.com/watch?v=Jiigjw8enQ8

After drinking a mysterious drug concocted by Amazonian shamans, Josh shares exclusive footage and insights into his own life-changing journey to the brink of the afterlife. Josh meets the leader of a movement attempting to beat death through technology.

Read more

A small device that contains human cells in a 3D matrix represents a giant leap in the ability of scientists to test how those cells respond to stresses, drugs and genetic changes. About the size of a thumb drive, the devices are known as tissue chips or organs on chips.

A series of investigations to test tissue chips in microgravity aboard the International Space Station is planned through a collaboration between the National Center for Advancing Translational Sciences (NCATS) at the National Institutes for Health (NIH) and the Center for the Advancement of Science in Space (CASIS) in partnership with NASA. The Tissue Chips in Space initiative seeks to better understand the role of microgravity on human health and disease and to translate that understanding to improved human health on Earth.

“Spaceflight causes many significant changes in the human body,” said Liz Warren, associate program scientist at CASIS. “We expect tissue chips in space to behave much like an astronaut’s body, experiencing the same kind of rapid change.”

Read more